Chinese advanced fusion-dependent lung cancer patients: Molecular spectrum and treatment options using next generation sequencing—A multicenter study (Yangtze River Delta Lung Cancer Cooperation Group-001).

Wenxian Wang,Chun-wei Xu,Ziming Li,Zhengbo Song,Wenfeng Fang,LiYun Miao,You-cai Zhu,Shirong zhang,Bin Bin Song,Xuefei Shi,Genhua Yu,Huafei Chen,Chuangzhou Rao,Jian Hui Huang,Ping Zhan,Hongbing Liu,Qian Wang,Tangfeng Lv,Yong Song,Shun Lu

Chinese advanced fusion-dependent lung cancer patients: Molecular spectrum and treatment options using next generation sequencing—A multicenter study (Yangtze River Delta Lung Cancer Cooperation Group-001).

2021

e21036Background: Lung cancer with drug receptor protein kinase fusion is regarded as a large class of molecular event, which is called fusion-dependent lung cancer. Fusion-dependent lung cancer ac...

Keywords:

Lung cancer
Medicine
treatment options
Internal medicine
yangtze river
Oncology
dependent lung
Drug receptor
Cancer
DNA sequencing
multicenter study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations